The E-Cigarette Summit will be held at the Royal College of Physicians (RCP) in London on Friday 9th December 2022. Alongside a milestone anniversary for the Summit, it is also 60 years since the RCP first published its ground breaking report “Smoking and Health”, which laid the foundations for tobacco control.
In the field of the economic implications of vaping products, Michael Pesko is among the leading experts: health economist and Associate Professor in the Department of Economics at Georgia State University, dr. Pesko is particularly interested in policy changes affecting the use of e-cigarettes. In this article, we provide a synthesis of his work on the economic impact of government and policy makers choices in the vaping market.
Riccardo Polosa: "In Italy, even today, we don't have a health policy that takes care of these people. Risk reduction represents the solution, an extraordinary opportunity for change and acceleration in terms of individual and public health. I consider it serious to insist on hiding from citizens the real opportunities offered by potentially low-risk instruments, even pointing them out as dangerous on a par with conventional cigarettes.
According to a qualitative analysis that involved the health personnel responsible for accompanying patients with schizophrenic spectrum disorders in their therapeutic paths, tobacco addiction is highly harmful and widespread among patients suffering from these disorders: doctors, psychologists and healthcare professionals in general have a positive view of smokeless instruments, which are considered an excellent substitute for smoking.
The third phase of the Replica project is in the prime of its activity: CoEHAR researchers successfully replicated the study published by Rudd and colleagues in 2020 and the data obtained not only show slight or no cytotoxic, mutagenic and genotoxic effects induced by the e-cigarette aerosol, but the work by researchers of Catania covered some methodological gaps and limitations in the original work.
"Risk reduction as a public health strategy to eradicate cigarette smoking", is going to be discussed in Rome on Wednesday 9th November as part of a conference promoted by Motor Health in the "Sala Cristallo" of Hotel Nazionale in Piazza Montecitorio.
prof. Riccardo Polosa, founder of the CoEHAR and one of the leading experts in the field of harm reduction strategies, will speak at the first edition of the congress "Le strade del Respiro", which will be held on Saturday 5 November in Rome.
As in the text, the experts believe that “Spanish authorities have a golden opportunity to apply new measures in the fight against the diseases caused by smoking that are giving significant results in those countries where they are already being applied”.
During the 2022 edition of GTNF, the Global Tobacco and Nicotine Forum, Prof. Riccardo Polosa, founder of the CoEHAR, was part of an intense and engaging panel on vaping and tobacco policies at the panel “Banned! Is Prohibition Back?”.
The In Silico Science research team conducted a series of robust and exhaustive systematic reviews to bring forward the best available evidence on the health effects of e-cigarettes on human health developing data for clinicians
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.